That's for GLIOMA. Patients already live a lot longer. It's a great and very positive event. We'll likely see DCVax-L results extended for Gliomas as well. And with combinations also. The UCLA PR today is a much bigger thing than a tweet. Ignoring that and then referring to this tweet and suggesting it's a negative for DCVax-L is not entirely unexpected from some, but it's a false light kind of distract. There is nothing negative and the day is filled with positives.